Electrostatic contributions drive the interaction between Staphylococcus aureus protein Efb-C and its complement target C3d

Protein Science

Volumn 17, Issue 11, 2008, Pages 1894-1906

  Haspel, Nurit ^a   Ricklin, Daniel ^b   Geisbrecht, Brian V ^c   Kavraki, Lydia E ^a   Lambris, John D ^b  

^a Rice University   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Complement; Computational analysis of protein structure; Efb C; Electrostatics; Hydrodynamics; Molecular mechanics dynamics; Proteins of the immune system; Structure; Thermodynamics

Indexed keywords

COMPLEMENT COMPONENT C3D; PROTEIN EFB C; STAPHYLOCOCCUS PROTEIN A; UNCLASSIFIED DRUG;

ARTICLE; CRYSTALLOGRAPHY; ELECTRICITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN INTERACTION; X RAY DIFFRACTION;

BACTERIAL PROTEINS; COMPLEMENT C3D; COMPUTATIONAL BIOLOGY; CRYSTALLIZATION; HUMANS; HYDROGEN BONDING; POINT MUTATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; STAPHYLOCOCCUS AUREUS; STATIC ELECTRICITY; THERMODYNAMICS; X-RAY DIFFRACTION;

STAPHYLOCOCCUS AUREUS;

EID: 55549143692     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1110/ps.036624.108     Document Type: Article

References (54)

1. Arfken, G. 1985. The method of steepest descents. In Mathematical methods for physicists, 3rd ed., pp. 428-436. Academic Press, Orlando, FL.
2. Baker, N.A., Sept, D., Joseph, S., Holst, M.J., and McCammon, J.A. 2001. Electrostatics of nanosystems: Application to microtubules and the ribosome. Proc. Natl. Acad. Sci. 98: 10037-10041.
3. Bernstein, F.C., Koetzle, T.F., Williams, G.J., Meyer Jr., E.F., Brice, M.D., Rodgers, J.R., Kennard, O., Shimanouchi, T., and Tasumi, M. 1977. The Protein Data Bank: A computer-based archival file for macromolecular structures. J. Mol. Biol. 112: 535-542.
4. Bonnet, P. and Bryce, R.A. 2005. Scoring binding affinity of multiple ligands using implicit solvent and a single molecular dynamics trajectory: Application to influenza neuraminidase. J. Mol. Graph. Model. 24: 147-156.
5. Brunger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros, P., Grosse-Kunstleve, R.W., Jiang, J.S., Kuszewski, J., Nilges, M., Pannu, N.S., et al. 1998. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54: 905-921.
6. Carroll, M.C. 2000. The role of complement in B cell activation and tolerance. Adv. Immunol. 74: 61-88.
7. Case, D.A., Darden, T.A., Cheathem III, T.E., Simmerling, C.L., Wang, J., Duke, R.E., Luo, R., Merz, K.M., Pearlman, D.A., and Crowley, M., et al. 2006. AMBER 9. University of California, San Francisco.
8. Chavakis, T., Preissner, K.T., and Herrmann, M. 2007. The anti-inflammatory activities of Staphylococcus aureus. Trends Immunol. 28: 408-418.
9. Chen, H., Schuster, M.C., Sfyroera, G., Geisbrecht, B.V., and Lambris, J.D. 2008. Solution insights into the structure of the Efb/C3 complement inhibitory complex as revealed by lysine acetylation and mass spectrometry. J. Am. Soc. Mass Spectrom. 19: 55-65.
10. Clemenza, L. and Isenman, D.E. 2000. Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21). J. Immunol. 165: 3839-3848.
11. Collaborative Computational Project Number 4. 1994. The CCP4 suite: Programs for protetin crystallography. Acta Crystallogr. D Biol. Crystallogr. 50: 760-763.
12. Duan, Y., Wu, C., Chowdhury, S., Lee, M.C., Xiong, G., Zhang, W., Yang, R., Cieplak, P., Luo, R., Lee, T., et al. 2003. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J. Comput. Chem. 24: 1999-2012.
13. Edinger, S.R., Cortis, C., Shenkin, P.S., and Friesner, R.A. 1997. Solvation free energies of peptides: Comparison of approximate continuum solvation models with accurate solution of the Poisson-Boltzmann equation. J. Phys. Chem. B 101: 1190-1197.
14. Fletcher, R. and Reeves, C.M. 1964. Function minimization by conjugate gradients. Comput. J. 7: 149. doi: 10.1093/comjnl/7.2.149.
15. Foster, T.J. 2005. Immune evasion by staphylococci. Nat. Rev. Microbiol. 3: 948-958.
16. Gilbert, H.E., Eaton, J.T., Hannan, J.P., Holers, V.M., and Perkins, S.J. 2005. Solution structure of the complex between CR2 SCR 1-2 and C3d of human complement: An X-ray scattering and sedimentation modelling study. J. Mol. Biol. 346: 859-873.
17. Hammel, M., Sfyroera, G., Pyrpassopoulos, S., Ricklin, D., Ramyar, K.X., Pop, M., Jin, Z., Lambris, J.D., and Geisbrecht, B.V. 2007a. Characterization of Ehp, a secreted complement inhibitory protein from Staphylococcus aureus. J. Biol. Chem. 282: 30051-30061.
18. Hammel, M., Sfyroera, G., Ricklin, D., Magotti, P., Lambris, J.D., and Geisbrecht, B.V. 2007b. A structural basis for complement inhibition by Staphylococcus aureus. Nat. Immunol. 8: 430-437.
19. Hannan, J.P., Young, K.A., Guthridge, J.M., Asokan, R., Szakonyi, G., Chen, X.S., and Holers, V.M. 2005. Mutational analysis of the complement receptor type 2 (CR2/CD21)-C3d interaction reveals a putative charged SCR1 binding site for C3d. J. Mol. Biol. 346: 845-858.
20. Hawkins, G.D., Cramer, C.J., and Truhlar, D.G. 1995. Pairwise solute descreening of solute charges from a dielectric medium. Chem. Phys. Lett. 246: 122-129.
21. Hawkins, G.D., Cramer, C.J., and Truhlar, D.G. 1996. Parametrized models of aqueous free energies of solvation based on pairwise descreening of solute atomic charges from a dielectric medium. J. Phys. Chem. 100: 19824-19839.
22. Hestenes, M.R. and Stiefel, E. 1952. Methods of conjugate gradients for solving linear systems. J. Res. Natl. Bur. Stand. 49: 409-436.
23. Holst, M. and Saied, F. 1993. Multigrid solution of the Poisson-Boltzmann equation. J. Comput. Chem. 14: 105-113.
24. Holst, M.J. and Saied, F. 1995. Numerical-solution of the nonlinear Poisson-Boltzmann equation-developing more robust and efficient methods. J. Comput. Chem. 16: 337-364.
25. Humphrey, W., Dalke, A., and Schulten, K. 1996. VMD: Visual molecular dynamics. J. Mol. Graph. 14: 33.
26. Janssen, B.J., Christodoulidou, A., McCarthy, A., Lambris, J.D., and Gros, P. 2006. Structure of C3b reveals conformational changes that underlie complement activity. Nature 444: 213-216.
27. Jongerius, I., Kohl, J., Pandey, M.K., Ruyken, M., van Kessel, K.P., van Strijp, J.A., and Rooijakkers, S.H. 2007. Staphylococcal complement evasion by various convertase-blocking molecules. J. Exp. Med. 204: 2461-2471.
28. Kollman, P.A., Massova, I., Reyes, C., Kuhn, B., Huo, S., Chong, L., Lee, M., Lee, T., Duan, Y., Wang, W., et al. 2000. Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models. Acc. Chem. Res. 33: 889-897.
29. Laich, A. and Sim, R.B. 2001. Complement C4bC2 complex formation: An investigation by surface plasmon resonance. Biochim. Biophys. Acta 1544: 96-112.
30. Laitinen, T., Kankare, J.A., and Perakyla, M. 2004. Free energy simulations and MM-PBSA analyses on the affinity and specificity of steroid binding to antiestradiol antibody. Proteins 55: 34-43.
31. Lambris, J.D., Ricklin, D., and Geisbrecht, B.V. 2008. Complement evasion by human pathogens. Nat. Rev. Microbiol. 6: 132-142.
32. Lee, L.Y., Hook, M., Haviland, D., Wetsel, R.A., Yonter, E.O., Syribeys, P., Vernachio, J., and Brown, E.L. 2004a. Inhibition of complement activation by a secreted Staphylococcus aureus protein. J. Infect. Dis. 190: 571-579.
33. Lee, L.Y., Liang, X., Hook, M., and Brown, E.L. 2004b. Identification and characterization of the C3 binding domain of the Staphylococcus aureus extracellular fibrinogen-binding protein (Efb). J. Biol. Chem. 279: 50710-50716.
34. Miyamoto, S. and Kollman, P.A. 1992. Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models. J. Comput. Chem. 13: 952-962.
35. Morikis, D. and Lambris, J.D. 2004. The electrostatic nature of C3d-complement receptor 2 association. J. Immunol. 172: 7537-7547.
36. Nagar, B., Jones, R.G., Diefenbach, R.J., Isenman, D.E., and Rini, J.M. 1998. X-ray crystal structure of C3d: A C3 fragment and ligand for complement receptor 2. Science 280: 1277-1281.
37. Nordahl, E.A., Rydengard, V., Nyberg, P., Nitsche, D.P., Morgelin, M., Malmsten, M., Bjorck, L., and Schmidtchen, A. 2004. Activation of the complement system generates antibacterial peptides. Proc. Natl. Acad. Sci. 101: 16879-16884.
38. Onufriev, A., Bashford, D., and Case, D.A. 2004. Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins 55: 383-394.
39. Pearlman, D.A., Case, D.A., Caldwell, J.W., Ross, W.S., Cheatham, T.E., Debolt, S., Ferguson, D., Seibel, G., and Kollman, P. 1995. AMBER, a package of computer-programs for applying molecular mechanics, normal-mode analysis, molecular-dynamics and free-energy calculations to simulate the structural and energetic properties of molecules. Comput. Phys. Commun. 91: 1-41.
40. Ricklin, D. and Lambris, J.D. 2007a. Complement-targeted therapeutics. Nat. Biotechnol. 25: 1265-1275.
41. Ricklin, D. and Lambris, J.D. 2007b. Exploring the complement interaction network using surface plasmon resonance. Adv. Exp. Med. Biol. 598: 260-278.
42. Sahu, A. and Lambris, J.D. 2001. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol. Rev. 180: 35-48.
43. Sarrias, M.R., Franchini, S., Canziani, G., Argyropoulos, E., Moore, W.T., Sahu, A., and Lambris, J.D. 2001. Kinetic analysis of the interactions of complement receptor 2 (CR2, CD21) with its ligands C3d, iC3b, and the EBV glycoprotein gp350/220. J. Immunol. 167: 1490-1499.
44. Sfyroera, G., Katragadda, M., Morikis, D., Isaacs, S.N., and Lambris, J.D. 2005. Electrostatic modeling predicts the activities of orthopoxvirus complement control proteins. J. Immunol. 174: 2143-2151.
45. Sinha, N. and Smith-Gill, S.J. 2002. Electrostatics in protein binding and function. Curr. Protein Pept. Sci. 3: 601-614.
46. Srinivasan, J., Trevathan, M.W., Beroza, P., and Case, D.A. 1999. Application of a pairwise Generalized Born model to proteins and nucleic acids: Inclusion of salt effects. Theor. Chem. Accts. 101: 426-434.
47. Still, W.C., Tempczyk, A., Hawley, R.C., and Hendrickson, T. 1990. Semi-analytical treatment of solvation for molecular mechanics and dynamics. J. Am. Chem. Soc. 112: 6127-6129.
48. Szakonyi, G., Guthridge, J.M., Li, D., Young, K., Holers, V.M., and Chen, X.S. 2001. Structure of complement receptor 2 in complex with its C3d ligand. Science 292: 1725-1728.
49. Thompson, J.D., Gibson, T.J., Plewniak, F., Jeanmougin, F., and Higgins, D.G. 1997. The CLUSTAL_X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25: 4876-4882.
50. Trieb, M., Rauch, C., Wibowo, F.R., Wellenzohn, B., and Liedl, K.R. 2004. Cooperative effects on the formation of intercalation sites. Nucleic Acids Res. 32: 4696-4703.
51. Tsui, V. and Case, D.A. 2000. Theory and applications of the Generalized Born solvation model in macromolecular simulations. Biopolymers 56: 275-291.
52. Weiser, J., Shenkin, P.S., and Still, W.C. 1999. Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO). J. Comput. Chem. 20: 217-230.
53. Wells, J.A. and McClendon, C.L. 2007. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450: 1001-1009.
54. Zemla, A. 2003. LGA: A method for finding 3D similarities in protein structures. Nucleic Acids Res. 31: 3370-3374.